Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
New York State Department of Health AIDS Institute HIV Quality of Care Clinical Advisory Committee– March 12th, 2015 Presentations are available at: http://www.hivguidelines.org/quality-of-care/nys-hiv-quality-of-careprogram/advisory-committee-meetings/2015-meetings/march-12-2015/ Sub-Committee Meetings and Report Back – Members of the Quality of Care Advisory committee met in four sub-committees: Tobacco Cessation; Access to Medications; Ending the Epidemic; and HCV Mono-Infection Indicators. Extended minutes of these meetings are available upon request to [email protected]. YAC/CAC Update – Adrian Centano, Michelle Lopez, and Julian Brown provided an update on the Consumer Advisory Committee and Young Adult consumer Advisory Committee. Facility Level Cascades – Providers from Mt. Sinai Institute for Advanced Medicine, Iris House, and Community Healthcare Network presented examples of facility level cascades that their institutions have created and discussed how these cascades can be used as tools for quality improvement. Proposed Quality Incentive for HIV SNPs – Frank Laufer provided an overview of the mainstream managed care quality incentive and presented on the proposed quality incentive for HIV SNPs. AMIDA Care Incentive Program – Dr. Oladipo Alao, Medical Director of the AMIDA Care Quality Program, provided an update on the AMIDA Care incentive program, aimed at improving the effectiveness and safety of medical and preventative care provided by the AMIDA Care Quality Program eHIVQUAL Update – Minna Yoshikawa, Emily Knudsen-Strong, Alexander Martin, and Daniel Feller presented the results from the 2013 eHIVQUAL Review. Results from the core review and new patient review (new to 2013) were discussed, including data about the newly diagnosed, viral load suppression, retention, sexually transmitted diseases, hepatitis C, substance use, and other indicators from the 2013 review. Further investigation into specific indicators such as syphilis treatment and HCV RNA assay for +HCVAbwill take place due to low scores. Complete data from the 2013 eHIVQUAL review will be available online and in a written report in the coming months. eHIVQUAL Feedback Survey – Emily Knudsen-Strong summarized the results of the 2013 eHIVQUAL Feedback Survey, distributed in January, 2015 to 185 Medical Directors and eHIVQUAL Coordinators from agencies that participated in the 2013 eHIVQUAL review. The most commonly reported barriers to submission were: 1) limited staff availability and staff turnover; 2) time-consuming process; 3) difficulty locating data in the internal record and data extraction from the EMR. Suggestions for improving the eHIVQUAL review process included: 1) additional webinars; 2) step-by-step instructions for the data upload process; 3) additional training and technical assistance for data entry staff; 4) inclusion of indicator definitions on generated reports; 5) online checklist of reviews due, deadlines, and status of submission; 7) improved functionality of the eHIVQUAL application (increase speed, reduce time-outs, resolve glitches, etc.). For further information on this meeting, please contact Jacob Lowy at [email protected]